New study examines dermal injections and their impact on skin aging

FEBRUARY 14, 2024by Tessa Roy,University of MichiganIncreased fibroblast synthetic activity as early as 1 week post-filler injection. Following injection of vehicle (saline) and filler (cross-li

Updated on: March 29,2024

New study examines dermal injections and their impact on skin aging

FEBRUARY 14, 2024by Tessa Roy,University of MichiganIncreased fibroblast synthetic activity as early as 1 week post-filler injection. Following injection of vehicle (saline) and filler (cross-li

Updated on:March 29,2024

LSD, a future anti-anxiety pill?

LSD, a future anti-anxiety pill?byMcGill UniversityCredit: CC0 Public DomainThe craze for psychedelics used for therapeutic purposes is real. However, the scientific evidence supporting their ef

Updated on: March 30,2024

LSD, a future anti-anxiety pill?

LSD, a future anti-anxiety pill?byMcGill UniversityCredit: CC0 Public DomainThe craze for psychedelics used for therapeutic purposes is real. However, the scientific evidence supporting their ef

Updated on:March 30,2024

Autophagy-tethering compounds may open new directions in targeted drug discovery

byScience China Press(A) Molecular glue ATTECs are targeting polyQ proteins in neurodegenerative disorders. (B) Bifunctional ATTECs targeting oncoprotein BRD4. (C) Bifunctional ATTECs targeting

Updated on: March 28,2024

Autophagy-tethering compounds may open new directions in targeted drug discovery

byScience China Press(A) Molecular glue ATTECs are targeting polyQ proteins in neurodegenerative disorders. (B) Bifunctional ATTECs targeting oncoprotein BRD4. (C) Bifunctional ATTECs targeting

Updated on:March 28,2024

Knowing how clinicians make real-world decisions about drug-drug interactions can improve patient safety

by Regenstrief InstituteDescriptive model of clinicians’ DDI decision-making process. This figure shows the coding tree developed during the inductive qualitative analysis, with primary themes sh

Updated on: January 26,2024

Knowing how clinicians make real-world decisions about drug-drug interactions can improve patient safety

by Regenstrief InstituteDescriptive model of clinicians’ DDI decision-making process. This figure shows the coding tree developed during the inductive qualitative analysis, with primary themes sh

Updated on:January 26,2024

Exploring ferumoxytol: A new frontier in MRI contrast agents

by Science China PressDuring the blood pool phase, it significantly shortens the T1and T2relaxation times of the blood, thus achieving bright blood effects in T1-weighted imaging and

Updated on: March 30,2024

Exploring ferumoxytol: A new frontier in MRI contrast agents

by Science China PressDuring the blood pool phase, it significantly shortens the T1and T2relaxation times of the blood, thus achieving bright blood effects in T1-weighted imaging and

Updated on:March 30,2024

A molecular route to decoding synaptic specificity and nerve cell communication

by Tokyo Institute of TechnologyThis study provides insights into the molecular mechanisms underlying the neuronal synaptic interaction. Credit: Tokyo TechNeurons or nerve cells are the fundament

Updated on: April 06,2024

A molecular route to decoding synaptic specificity and nerve cell communication

by Tokyo Institute of TechnologyThis study provides insights into the molecular mechanisms underlying the neuronal synaptic interaction. Credit: Tokyo TechNeurons or nerve cells are the fundament

Updated on:April 06,2024

COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir

by Elana GotkineFor patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116 or nirmatrelvir-ritonavir, accord

Updated on: March 28,2024

COVID-19 viral load rebound can occur after VV116, nirmatrelvir-ritonavir

by Elana GotkineFor patients with mild-to-moderate COVID-19, viral load rebound and symptom rebound can occur after a standard five-day course of treatment with VV116 or nirmatrelvir-ritonavir, accord

Updated on:March 28,2024

Fighting obesity: The GLP-1 revolution

Updated on: September 24,2024

Fighting obesity: The GLP-1 revolution

Updated on:September 24,2024

Higher-dose naloxone spray didn't save more lives, researchers find by Mike Stobbe

by Mike StobbeThis image provided by Hikma Pharmaceuticals shows the company's nasal spray drug Kloxxado, containing 8 milligrams of naloxone. A study published Thursday, Feb. 8, 2024 finds that a

Updated on: March 21,2024

Higher-dose naloxone spray didn't save more lives, researchers find by Mike Stobbe

by Mike StobbeThis image provided by Hikma Pharmaceuticals shows the company's nasal spray drug Kloxxado, containing 8 milligrams of naloxone. A study published Thursday, Feb. 8, 2024 finds that a

Updated on:March 21,2024

FDA asked to consider party drug MDMA as treatment for PTSD

by Robin FosterA California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stre

Updated on: January 26,2024

FDA asked to consider party drug MDMA as treatment for PTSD

by Robin FosterA California company has asked the U.S. Food and Drug Administration to approve MDMA, the active ingredient in party drugs like molly and ecstasy, as a treatment for post-traumatic stre

Updated on:January 26,2024

AI and Plasma Proteomics: Predicting Parkinson’s Disease 7 Years in Advance

Updated on: June 19,2024

AI and Plasma Proteomics: Predicting Parkinson’s Disease 7 Years in Advance

Updated on:June 19,2024

Experimental drug that alters gut microbiome shows promise for long COVID relief

by Mary Van Beusekom, CIDRAPProportion of PACS symptoms alleviation by six months. Credit:The Lancet Infectious Diseases(2023). DOI: 10.1016/S1473-3099(23)00685-0A randomized controlled tr

Updated on: January 26,2024

Experimental drug that alters gut microbiome shows promise for long COVID relief

by Mary Van Beusekom, CIDRAPProportion of PACS symptoms alleviation by six months. Credit:The Lancet Infectious Diseases(2023). DOI: 10.1016/S1473-3099(23)00685-0A randomized controlled tr

Updated on:January 26,2024